• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Claritev and Lantern Form Strategic Partnership to Enhance Surgical Cost Transparency and Positively Impact Care Quality and Cost Savings

    5/7/25 8:00:00 AM ET
    $CTEV
    Business Services
    Consumer Discretionary
    Get the next $CTEV alert in real time by email

    The partnership integrates Claritev's innovative solutions with Lantern's Specialty Care Platform to optimize healthcare costs for Lantern's footprint.

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced an agreement with Lantern, a Specialty Care Platform that helps employers reduce costs and improve health outcomes for surgery, cancer and infusions care. This strategic partnership brings together Claritev's award-winning BenInsights® and HST Connect® solutions with Lantern's Network of Excellence and TrueRateTM savings methodology to create a powerful solution for healthcare cost optimization that ultimately lowers costs in the healthcare ecosystem.

    This collaboration builds upon previous joint research, enabling Claritev and Lantern to provide enhanced value to employers, as well as the healthcare services that patients receive through data-driven surgical cost analysis and healthcare cost optimization.

    "This partnership is another step forward in Claritev's transformation journey," said Travis Dalton, Chairman, CEO and President of Claritev. "Lantern shares the same commitment as Claritev - to improve healthcare affordability and transparency in the U.S. Our previous collaboration with them on surgical episode costs reinforced what an impactful partnership this is, and we look forward to delivering meaningful savings for employer groups while increasing the quality of care a patient receives."

    Claritev and Lantern will combine Claritev's data capabilities with Lantern's surgical bundling methodology to provide enhanced value through validated cost optimization opportunities in two ways:

    • Enhanced Data Analytics with BenInsights – Claritev's comprehensive platform unifies financial and clinical data to deliver a 360-degree view of healthcare spending patterns and benefit plan design through configurable reporting and Smart Card technology. With added access to Lantern's surgical network, BenInsights will provide clients with unprecedented visibility into surgical cost variations and concrete opportunities for optimized care pathways and substantial savings.
    • Optimized Patient Steering with HST Connect – Claritev's HST Connect will integrate Lantern's surgical network and services to help guide patients to high-quality, cost-effective providers to enhance patient experience and improve patient care.

    "Surgery is 20% of an employer's health spend, but the pricing for those episodes has been nearly impossible to unpack. We published our TrueRateTM savings methodology to increase transparency and encourage the market to adopt our repeatable formula as the new industry standard," said Dickon Waterfield, President of Lantern. "Our partnership with Claritev allows us to transform those innovative insights into actionable tools that will deliver even more specialty care cost savings for our clients."

    About Claritev

    Claritev, formerly known as MultiPlan, is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality to the U.S. healthcare system. Led by a team of deeply experienced associates, data scientists and innovators, Claritev provides cutting-edge solutions and services fueled by over 40 years of claims processing data. Claritev leverages world-class technology and AI to power a robust enterprise platform that delivers meaningful insights to drive affordability and price transparency and optimizes networks and benefits design in healthcare. By developing purpose-built solutions that support all key stakeholders — including payors, employers, patients, providers and third parties — Claritev is dedicated to making healthcare more accessible and affordable for all.

    Claritev serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit claritev.com.

    About Lantern

    Lantern is the specialty care platform connecting people with the best care when they need it most. By curating a Network of Excellence comprised of the nation's top specialists for surgery, cancer care, infusions and more, Lantern delivers excellent care with significant cost savings to employers and their workforces. Lantern also pairs members with a dedicated care team, including Care Advocates and nurses, for the entirety of their care journey, helping them get back to good health, back to their families and back to work. With convenient access to specialists nationwide, Lantern means quality care is within driving distance for most. Lantern is trusted by the nation's largest employers to deliver care to more than 6 million members across the country. Learn more about us at lanterncare.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250506543825/en/

    Claritev Media Relations

    Pamela Walker

    VP, Corporate Marketing

    Claritev

    781-895-3118

    [email protected]



    Claritev Investor Relations

    Jason Wong

    SVP, Treasury & Investor Relations

    Claritev

    866-909-7427

    [email protected]



    Shawna Gasik

    AVP, Investor Relations

    Claritev

    866-909-7427

    [email protected]

    Get the next $CTEV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CTEV

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CTEV
    Leadership Updates

    Live Leadership Updates

    See more
    • Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks

      HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and data insights company focused on making healthcare more affordable, transparent and fair for all. This network participation agreement marks a major step forward in expanding access to high-quality, convenient, and personalized speech therapy services for individuals and families nationwide. Great Speech's innovative teletherapy services will now be available to health plan members accessing Claritev's MultiPlan and PHCS Networks. The initiative aims to eliminate traditio

      5/6/25 10:02:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Appoints Jason Kap to its Board of Directors

      Board gains deep technology and innovation expertise to support Claritev's tech-driven growth strategy Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, yesterday announced the appointment of Jason Kap to its Board of Directors, effective immediately following his election at the Company's Annual Meeting of Shareholders on April 30, 2025. Kap brings more than two decades of leadership experience driving technology, pricing and product transformation strategies across the software and services industries, strengthening Claritev's focus on building a next-generati

      5/1/25 8:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    SEC Filings

    See more
    • SEC Form S-8 filed by Claritev Corporation

      S-8 - Claritev Corp (0001793229) (Filer)

      5/9/25 8:05:24 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • SEC Form 10-Q filed by Claritev Corporation

      10-Q - Claritev Corp (0001793229) (Filer)

      5/9/25 7:40:59 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Claritev Corp (0001793229) (Filer)

      5/8/25 6:04:59 AM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Claritev Corporation Reports First Quarter 2025 Results

      – Q1 2025 Revenues of $231.3 million, Net Loss of $71.3 million, and Adjusted EBITDA of $142.1 million (Adjusted EBITDA Margin of 61.4%) – Reaffirms full-year guidance Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2025. "There is tremendous excitement at Claritev as we kick off 2025 - our ‘Year of The Turn.' We've already announced major milestones, and our teams are amplifying this positive momentum as we continue on our planned course for the year," said Travis Dalton, Chairman, CEO a

      5/8/25 6:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev and Lantern Form Strategic Partnership to Enhance Surgical Cost Transparency and Positively Impact Care Quality and Cost Savings

      The partnership integrates Claritev's innovative solutions with Lantern's Specialty Care Platform to optimize healthcare costs for Lantern's footprint. Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced an agreement with Lantern, a Specialty Care Platform that helps employers reduce costs and improve health outcomes for surgery, cancer and infusions care. This strategic partnership brings together Claritev's award-winning BenInsights® and HST Connect® solutions with Lantern's Network of Excellence and TrueRateTM savings methodology to create a pow

      5/7/25 8:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks

      HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and data insights company focused on making healthcare more affordable, transparent and fair for all. This network participation agreement marks a major step forward in expanding access to high-quality, convenient, and personalized speech therapy services for individuals and families nationwide. Great Speech's innovative teletherapy services will now be available to health plan members accessing Claritev's MultiPlan and PHCS Networks. The initiative aims to eliminate traditio

      5/6/25 10:02:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Financials

    Live finance-specific insights

    See more

    $CTEV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Claritev Corporation Reports First Quarter 2025 Results

      – Q1 2025 Revenues of $231.3 million, Net Loss of $71.3 million, and Adjusted EBITDA of $142.1 million (Adjusted EBITDA Margin of 61.4%) – Reaffirms full-year guidance Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2025. "There is tremendous excitement at Claritev as we kick off 2025 - our ‘Year of The Turn.' We've already announced major milestones, and our teams are amplifying this positive momentum as we continue on our planned course for the year," said Travis Dalton, Chairman, CEO a

      5/8/25 6:00:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Claritev Corporation Announces First Quarter 2025 Earnings Conference Call

      Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its first quarter 2025 financial results on Thursday, May 8, 2025, and hold its conference call that morning at 8:00 am Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to: https://www.netroadshow.com/events/login?show=fda0

      4/10/25 8:30:00 AM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Pres., CEO & Executive Chair Dalton Travis bought $100,823 worth of shares (5,252 units at $19.20), increasing direct ownership by 2% to 239,285 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      3/10/25 4:43:36 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • EVP&CFO Garis Douglas Michael bought $175,891 worth of shares (8,919 units at $19.72) (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      3/10/25 4:42:04 PM ET
      $CTEV
      Business Services
      Consumer Discretionary

    $CTEV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Kap Jason Lamar was granted 7,356 shares (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/2/25 4:39:27 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • SEC Form 3 filed by new insider Kap Jason Lamar

      3 - Claritev Corp (0001793229) (Issuer)

      5/2/25 4:37:20 PM ET
      $CTEV
      Business Services
      Consumer Discretionary
    • Director Klapstein Julie D was granted 7,356 shares, increasing direct ownership by 89% to 15,634 units (SEC Form 4)

      4 - Claritev Corp (0001793229) (Issuer)

      5/2/25 4:36:05 PM ET
      $CTEV
      Business Services
      Consumer Discretionary